International Space Station
[[File:ISS_configuration_2022-12_en.svg
International Space Station
The International Space Station (ISS) is a modular space station (habitable artificial satellite) in low Earth orbit. It is a multinational collaborative project involving five participating space agencies: NASA (United States), Roscosmos (Russia), JAXA (Japan), ESA (Europe), and CSA (Canada). The ISS serves as a microgravity and space environment research laboratory in which scientific research is conducted in astrobiology, astronomy, meteorology, physics, and other fields. The station is divided into two sections, the Russian Orbital Segment (ROS), which is operated by Russia, and the United States Orbital Segment (USOS), which is shared by many nations.
History
The ISS program began in 1998, with the launch of the Russian module Zarya, which was followed by the United States module Unity. The station has been continuously occupied since the arrival of Expedition 1 in November 2000. The last pressurized module was fitted in 2011, with an experimental inflatable space habitat added in 2016. Development and assembly of the station continue, with several new elements scheduled for launch in the coming years.
Structure and Components
The ISS consists of pressurized modules, external trusses, solar arrays, and other components. ISS components have been launched by Russian Proton and Soyuz rockets, and the American Space Shuttles. The station's modular design allows for the addition of new modules to expand its capabilities. Key modules include the Zvezda service module, which provides living quarters for the crew, and the Destiny laboratory module, where much of the scientific research is conducted.
Life Aboard the ISS
Crew members aboard the ISS experience a day/night cycle every 90 minutes, with 16 sunrises and sunsets per day. Microgravity affects various physiological systems; thus, astronauts must exercise daily to mitigate muscle and bone loss. Research conducted aboard the ISS often focuses on the effects of long-term spaceflight on the human body, which is critical for planning future long-duration missions to destinations such as Mars.
Scientific Research
The ISS provides a platform for a wide range of scientific research, which is impossible or difficult to conduct on Earth. This includes studies on the long-term effects of microgravity on the human body, the testing of technologies for space exploration, and research in various scientific fields. The results of these studies are used to improve our understanding of fundamental scientific principles and to develop new technologies.
International Cooperation
The ISS is a prime example of international cooperation in space exploration. It involves agencies from the United States, Russia, Europe, Japan, and Canada, along with contributions from other countries. The station's operation and management are shared among the participating nations, with English and Russian being the working languages.
Future of the ISS
The future of the ISS is a subject of discussion and planning. While the station has been authorized to operate through at least 2024, there is discussion among the partner nations about its operation beyond that, with proposals for its use extending to 2028 or beyond. There are also discussions about the potential for commercial involvement in the ISS, either through private modules attached to the station or private companies taking over operations of certain parts.
This article is a space- or spaceflight-related stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD